• Tue, December 12, 2023

Derik De Bruin Upgraded (TXG) to Hold and Increased Target to $54 on, Dec 12th, 2023

Derik De Bruin of B of A Securities, Upgraded "10x Genomics, Inc." (TXG) to Hold and Increased Target from $36 to $54 on, Dec 12th, 2023.

Derik has made no other calls on TXG in the last 4 months.



There are 2 other peers that have a rating on TXG. Out of the 2 peers that are also analyzing TXG, 0 agree with Derik's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Derik


  • Luke Sergott of "Barclays" Maintained at Buy with Decreased Target to $47 on, Friday, September 29th, 2023
  • Kyle Mikson of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $70 on, Tuesday, September 19th, 2023

Like: 👍